Brian Rood

561 total citations
6 papers, 385 citations indexed

About

Brian Rood is a scholar working on Genetics, Neurology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Brian Rood has authored 6 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 4 papers in Neurology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Brian Rood's work include Glioma Diagnosis and Treatment (6 papers), Neuroblastoma Research and Treatments (4 papers) and Neurofibromatosis and Schwannoma Cases (2 papers). Brian Rood is often cited by papers focused on Glioma Diagnosis and Treatment (6 papers), Neuroblastoma Research and Treatments (4 papers) and Neurofibromatosis and Schwannoma Cases (2 papers). Brian Rood collaborates with scholars based in United States, Australia and Canada. Brian Rood's co-authors include Roger J. Packer, Tobey J. MacDonald, Michael J. Fisher, Tina Young Poussaint, Larry E. Kun, Sridharan Gururangan, Henry S. Friedman, Richard J. Gilbertson, Susan Chi and Sridhar Vajapeyam and has published in prestigious journals such as Journal of Clinical Oncology, Neuro-Oncology and Pediatric Blood & Cancer.

In The Last Decade

Brian Rood

6 papers receiving 379 citations

Peers

Countries citing papers authored by Brian Rood

Since Specialization

Citations

This map shows the geographic impact of Brian Rood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Rood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Rood more than expected).

Fields of papers citing papers by Brian Rood

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Rood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Rood. The network helps show where Brian Rood may publish in the future.

Co-authorship network of co-authors of Brian Rood

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Rood. A scholar is included among the top collaborators of Brian Rood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Rood. Brian Rood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

#	Work	Indexed citations
1	IMMU-19. Outcomes of Pediatric Patients with High-Risk CNS Tumors Treated with Multi-tumor associated antigen specific T cell (TAA-T) therapy: the ReMIND trial 2022 ·Neuro-Oncology ·Eugene I. Hwang, (unknown), (unknown), (unknown), Melanie Grant, Haili Lang, (unknown), (unknown), (unknown), (unknown), (unknown), Fahmida Hoq, Patrick J. Hanley, Lindsay Kilburn, Brian Rood, Roger Packer, Catherine M. Bollard	1
2	Implications of new understandings of gliomas in children and adults with NF1: report of a consensus conference 2020 ·Neuro-Oncology ·Roger J. Packer, Antonio Iavarone, David Jones, Jaishri O. Blakeley, Éric Bouffet, Michael J. Fisher, Eugene Hwang, Cynthia Hawkins, Lindsay Kilburn, Tobey J. MacDonald, Stefan M. Pfister, Brian Rood, Fausto J. Rodríguez, Uri Tabori, Vijay Ramaswamy, Yuan Zhu, Jason Fangusaro, Stephen Albert Johnston, David H. Gutmann	40
3	A feasibility and efficacy study of rapamycin and erlotinib for recurrent pediatric low‐grade glioma (LGG) 2012 ·Pediatric Blood & Cancer ·Michal Yalon, Brian Rood, Tobey J. MacDonald, Geoffrey McCowage, (unknown), Shlomi Constantini, Roger J. Packer	48
4	Lack of Efficacy of Bevacizumab Plus Irinotecan in Children With Recurrent Malignant Glioma and Diffuse Brainstem Glioma: A Pediatric Brain Tumor Consortium Study 2010 ·Journal of Clinical Oncology ·Sridharan Gururangan, Susan Chi, Tina Young Poussaint, Arzu Onar‐Thomas, Richard J. Gilbertson, Sridhar Vajapeyam, Henry S. Friedman, Roger J. Packer, Brian Rood, James M. Boyett, Larry E. Kun	152
5	Objective response of multiply recurrent low‐grade gliomas to bevacizumab and irinotecan 2009 ·Pediatric Blood & Cancer ·Roger J. Packer, Regina I. Jakacki, Marianna Horn, Brian Rood, Gilbert Vézina, Tobey J. MacDonald, Michael J. Fisher, Bruce H. Cohen	100
6	Feasibility of metronomic maintenance chemotherapy following high‐dose chemotherapy for malignant central nervous system tumors 2007 ·Pediatric Blood & Cancer ·Leslie Choi, Brian Rood, Naynesh Kamani, (unknown), Roger J. Packer, Maria Rita Santi, Tobey J. MacDonald	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact